1. Factors predictive of durable HIV suppression in a randomized double blind trial with nevirapine, zidovudine and lamivudine in treatment-naive patients with advanced AIDS;Pollard,2000
2. Comparison of antiviral response with abacavir/combivir to indinavir/combivir in therapy-naive adults at 48 weeks (CNA 3005);Staszewski,1999
3. The Atlantic study: a randomized, open-label trial comparing two protease inhibitor-sparing antiretroviral strategies versus a standard PI-containing regimen, 48 week data;Murphy,1999
4. Longer time to treatment failure and durability of response with efavirenz+ZDV+3TC: first analysis of full 1266 patients cohort from study 006;Staszewski,1999
5. Sustained plasma viral burden reductions and CD4 increases in HIV-1 infected patients with rescriptor+retrovir+epivir;Sargent,1998